Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010) (ISBN 0309151295) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (2007) (ISBN 030910386X) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• Improving the Quality of Cancer Clinical Trials:Workshop Summary (2008) (ISBN 0309116686) Margie Patlak and Sharyl Nass, Rapporteurs


• Scientific Standards for Studies on Modified Risk Tobacco Products (2012) (ISBN 0309223989) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships: Workshop Summary (2008) (ISBN 0309108896) Miriam Davis, Sarah Hanson, Bruce Altevogt, Rapporteurs, Forum on Neuroscience and Nervous System Disorders, Institute of Medicine


• Accelerating the Development of Biomarkers for Drug Safety:Workshop Summary (2009) (ISBN 0309131243) Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Evolution of Translational Omics: Lessons Learned and the Path Forward (2012) (ISBN 0309224187) Christine M. Micheel, Sharly J. Nass, and Gilbert S. Omenn, Editors; Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine


• Assessing and Improving Value in Cancer Care:Workshop Summary (2009) (ISBN 0309138140) Adam Schickedanz, Rapporteur; Institute of Medicine


• Policy Issues in the Development of Personalized Medicine in Oncology:Workshop Summary (2010) (ISBN 0309145759) Margie Patlak and Laura Levit, Rapporteurs; Institute of Medicine


• Animal Models for Assessing Countermeasures to Bioterrorism Agents (2011) (ISBN 0309219094) Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents; National Research Council


• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (2012) (ISBN 0309225493) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary (2011) (ISBN 0309212219) Diana E. Pankevich, Miriam Davis, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Institute of Medicine


• Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (2012) (ISBN 0309261163) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine